Unknown

Dataset Information

SGLT2 Inhibitors in Long COVID Syndrome: Is There a Potential Role?


ABSTRACT: The coronavirus disease (COVID)-19 has turned into a pandemic causing a global public health crisis. While acute COVID-19 mainly affects the respiratory system and can cause acute respiratory distress syndrome, an association with persistent inflammatory stress affecting different organ systems has been elucidated in long COVID syndrome (LCS). Increased severity and mortality rates have been reported due to cardiophysiological and metabolic systemic disorders as well as multiorgan failure in COVID-19, additionally accompanied by chronic dyspnea and fatigue in LCS. Hence, novel therapies have been tested to improve the outcomes of LCS of which one potential candidate might be sodium-glucose cotransporter 2 (SGLT2) inhibitors. The aim of this narrative review was to discuss rationales for in

SUBMITTER: Zimmermann P 

PROVIDER: S-EPMC10744331 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature